Publications by authors named "Michael Hecker"

Claim this Profile
C
Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany.
Michael Hecker, Birgit Berger, Niklas Frahm, Felicita Heidler, Bassel Barhoum

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.
Michael Hecker, Brit Fitzner, Isis Ludwig-Portugall, Friederike Bohne, Edmar Heyland

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal Study.
Felicita Heidler, Michael Hecker, Niklas Frahm, Julia Baldt, Silvan Elias Langhorst

J Clin Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 Pandemic.
Felicita Heidler, Michael Hecker, Niklas Frahm, Julia Baldt, Barbara Streckenbach

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the general stress response sigma factor SigB prevents competence development in .
Marco Harms, Stephan Michalik, Petra Hildebrandt, Marc Schaffer, Manuela Gesell Salazar, Michael Hecker

mBio· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy.
Janina Meißner, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar

Ther Adv Neurol Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in monitoring the quality of care in multiple sclerosis.
Uwe Klaus Zettl, Niklas Frahm, Michael Hecker

Lancet Reg Health Eur· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse.
Michael Hecker, Brit Fitzner, Dirk Koczan, Juliane Klehmet, Matthias Grothe

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis.
Katja Burian, Felicita Heidler, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis.
Andreas Körtge, Anne Breitrück, Sandra Doß, Jacqueline Hofrichter, Sophie-Charlotte Nelz, Michael Hecker

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis.
Michael Hecker, Niklas Frahm, Uwe Klaus Zettl

Pharmaceutics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation.
Uwe Klaus Zettl, Paulus Stefan Rommer, Orhan Aktas, Torsten Wagner, Joachim Richter, Michael Hecker

Expert Rev Clin Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy.
Michael Hecker, Brit Fitzner, Nina Boxberger, Elena Putscher, Robby Engelmann

J Neuroinflammation· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis.
Julia Baldt, Niklas Frahm, Michael Hecker, Barbara Streckenbach, Silvan Elias Langhorst

J Clin Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia.
Robby Engelmann, Nadja Jaekel, Sabrina Jotschke, Beatrice Ludwig-Kraus, Frank Bernhard Kraus, Michael Hecker

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy.
Marie-Celine Haker, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar

Ther Adv Drug Saf· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations.
Franziska Alfen, Elena Putscher, Michael Hecker, Uwe Klaus Zettl, Andreas Hermann

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing.
Elena Putscher, Michael Hecker, Brit Fitzner, Nina Boxberger, Margit Schwartz

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer proteomic map of 949 human cell lines.
Emanuel Gonçalves, Rebecca C Poulos, Zhaoxiang Cai, Syd Barthorpe, Srikanth S Manda, Michael Hecker

Cancer Cell· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, Pegah Mashhadiakbar, Silvan Elias Langhorst, Michael Hecker

Ther Adv Chronic Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
Michael Hecker, Niklas Frahm, Paula Bachmann, Jane Louisa Debus, Marie-Celine Haker

Front Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis.
Michael Hecker, Brit Fitzner, Elena Putscher, Margit Schwartz, Alexander Winkelmann

EBioMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis.
Silvan Elias Langhorst, Niklas Frahm, Michael Hecker, Pegah Mashhadiakbar, Barbara Streckenbach

J Pers Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy.
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, Pegah Mashhadiakbar, Silvan Elias Langhorst, Michael Hecker

Pharmaceutics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.
Michael Hecker, Jan Bühring, Brit Fitzner, Paulus Stefan Rommer, Uwe Klaus Zettl

Biomolecules· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis